nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—Bone marrow depression—Vincristine—muscle cancer	0.0333	0.0333	CcSEcCtD
Carbimazole—Aplastic anaemia—Dactinomycin—muscle cancer	0.0236	0.0236	CcSEcCtD
Carbimazole—Mouth ulceration—Dactinomycin—muscle cancer	0.0228	0.0228	CcSEcCtD
Carbimazole—Mouth ulceration—Vincristine—muscle cancer	0.0203	0.0203	CcSEcCtD
Carbimazole—Liver function test abnormal—Dactinomycin—muscle cancer	0.0169	0.0169	CcSEcCtD
Carbimazole—Mouth ulceration—Etoposide—muscle cancer	0.0165	0.0165	CcSEcCtD
Carbimazole—Bone marrow depression—Methotrexate—muscle cancer	0.0162	0.0162	CcSEcCtD
Carbimazole—Liver disorder—Methotrexate—muscle cancer	0.016	0.016	CcSEcCtD
Carbimazole—Pancytopenia—Dactinomycin—muscle cancer	0.015	0.015	CcSEcCtD
Carbimazole—Neutropenia—Dactinomycin—muscle cancer	0.0148	0.0148	CcSEcCtD
Carbimazole—Bone marrow depression—Doxorubicin—muscle cancer	0.014	0.014	CcSEcCtD
Carbimazole—Stomatitis—Dactinomycin—muscle cancer	0.0137	0.0137	CcSEcCtD
Carbimazole—Pancytopenia—Vincristine—muscle cancer	0.0134	0.0134	CcSEcCtD
Carbimazole—Neutropenia—Vincristine—muscle cancer	0.0132	0.0132	CcSEcCtD
Carbimazole—Agranulocytosis—Dactinomycin—muscle cancer	0.0131	0.0131	CcSEcCtD
Carbimazole—Hepatitis—Dactinomycin—muscle cancer	0.0126	0.0126	CcSEcCtD
Carbimazole—Stomatitis—Vincristine—muscle cancer	0.0123	0.0123	CcSEcCtD
Carbimazole—Ageusia—Doxorubicin—muscle cancer	0.0117	0.0117	CcSEcCtD
Carbimazole—Alopecia—Dactinomycin—muscle cancer	0.0112	0.0112	CcSEcCtD
Carbimazole—Pancytopenia—Etoposide—muscle cancer	0.0109	0.0109	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—muscle cancer	0.0108	0.0108	CcSEcCtD
Carbimazole—Neutropenia—Etoposide—muscle cancer	0.0107	0.0107	CcSEcCtD
Carbimazole—Angiopathy—Vincristine—muscle cancer	0.0102	0.0102	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—muscle cancer	0.0102	0.0102	CcSEcCtD
Carbimazole—Ill-defined disorder—Dactinomycin—muscle cancer	0.0102	0.0102	CcSEcCtD
Carbimazole—Alopecia—Vincristine—muscle cancer	0.00998	0.00998	CcSEcCtD
Carbimazole—Stomatitis—Etoposide—muscle cancer	0.00993	0.00993	CcSEcCtD
Carbimazole—Jaundice—Etoposide—muscle cancer	0.00993	0.00993	CcSEcCtD
Carbimazole—Malaise—Dactinomycin—muscle cancer	0.00992	0.00992	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—muscle cancer	0.00987	0.00987	CcSEcCtD
Carbimazole—Leukopenia—Dactinomycin—muscle cancer	0.00985	0.00985	CcSEcCtD
Carbimazole—Agranulocytosis—Etoposide—muscle cancer	0.00951	0.00951	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—muscle cancer	0.00945	0.00945	CcSEcCtD
Carbimazole—Myalgia—Dactinomycin—muscle cancer	0.00937	0.00937	CcSEcCtD
Carbimazole—Discomfort—Dactinomycin—muscle cancer	0.00926	0.00926	CcSEcCtD
Carbimazole—Infection—Dactinomycin—muscle cancer	0.00892	0.00892	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—muscle cancer	0.00887	0.00887	CcSEcCtD
Carbimazole—Leukopenia—Vincristine—muscle cancer	0.0088	0.0088	CcSEcCtD
Carbimazole—Thrombocytopenia—Dactinomycin—muscle cancer	0.00879	0.00879	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—muscle cancer	0.00854	0.00854	CcSEcCtD
Carbimazole—Myalgia—Vincristine—muscle cancer	0.00837	0.00837	CcSEcCtD
Carbimazole—Angiopathy—Etoposide—muscle cancer	0.0083	0.0083	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00818	0.00818	CcSEcCtD
Carbimazole—Alopecia—Etoposide—muscle cancer	0.00808	0.00808	CcSEcCtD
Carbimazole—Infection—Vincristine—muscle cancer	0.00797	0.00797	CcSEcCtD
Carbimazole—Nervous system disorder—Vincristine—muscle cancer	0.00787	0.00787	CcSEcCtD
Carbimazole—Thrombocytopenia—Vincristine—muscle cancer	0.00786	0.00786	CcSEcCtD
Carbimazole—Feeling abnormal—Dactinomycin—muscle cancer	0.0074	0.0074	CcSEcCtD
Carbimazole—Ill-defined disorder—Etoposide—muscle cancer	0.00739	0.00739	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—muscle cancer	0.00731	0.00731	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00731	0.00731	CcSEcCtD
Carbimazole—Malaise—Etoposide—muscle cancer	0.00718	0.00718	CcSEcCtD
Carbimazole—Leukopenia—Etoposide—muscle cancer	0.00713	0.00713	CcSEcCtD
Carbimazole—Body temperature increased—Dactinomycin—muscle cancer	0.0071	0.0071	CcSEcCtD
Carbimazole—Eosinophilia—Methotrexate—muscle cancer	0.00678	0.00678	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00673	0.00673	CcSEcCtD
Carbimazole—Discomfort—Etoposide—muscle cancer	0.0067	0.0067	CcSEcCtD
Carbimazole—Hypersensitivity—Dactinomycin—muscle cancer	0.00662	0.00662	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—muscle cancer	0.0065	0.0065	CcSEcCtD
Carbimazole—Infection—Etoposide—muscle cancer	0.00646	0.00646	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—muscle cancer	0.0064	0.0064	CcSEcCtD
Carbimazole—Thrombocytopenia—Etoposide—muscle cancer	0.00636	0.00636	CcSEcCtD
Carbimazole—Body temperature increased—Vincristine—muscle cancer	0.00634	0.00634	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—muscle cancer	0.00633	0.00633	CcSEcCtD
Carbimazole—Skin disorder—Etoposide—muscle cancer	0.00631	0.00631	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—muscle cancer	0.00595	0.00595	CcSEcCtD
Carbimazole—Hypersensitivity—Vincristine—muscle cancer	0.00591	0.00591	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—muscle cancer	0.00587	0.00587	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—muscle cancer	0.0057	0.0057	CcSEcCtD
Carbimazole—Rash—Dactinomycin—muscle cancer	0.00566	0.00566	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—muscle cancer	0.00563	0.00563	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—muscle cancer	0.00554	0.00554	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—muscle cancer	0.00551	0.00551	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—muscle cancer	0.00548	0.00548	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—muscle cancer	0.00548	0.00548	CcSEcCtD
Carbimazole—Feeling abnormal—Etoposide—muscle cancer	0.00536	0.00536	CcSEcCtD
Carbimazole—Nausea—Dactinomycin—muscle cancer	0.00533	0.00533	CcSEcCtD
Carbimazole—Urticaria—Etoposide—muscle cancer	0.00516	0.00516	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—muscle cancer	0.00515	0.00515	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—muscle cancer	0.00515	0.00515	CcSEcCtD
Carbimazole—Body temperature increased—Etoposide—muscle cancer	0.00514	0.00514	CcSEcCtD
Carbimazole—Rash—Vincristine—muscle cancer	0.00506	0.00506	CcSEcCtD
Carbimazole—Dermatitis—Vincristine—muscle cancer	0.00505	0.00505	CcSEcCtD
Carbimazole—Headache—Vincristine—muscle cancer	0.00503	0.00503	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—muscle cancer	0.00497	0.00497	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—muscle cancer	0.00493	0.00493	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—muscle cancer	0.00484	0.00484	CcSEcCtD
Carbimazole—Hypersensitivity—Etoposide—muscle cancer	0.00479	0.00479	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—muscle cancer	0.00477	0.00477	CcSEcCtD
Carbimazole—Nausea—Vincristine—muscle cancer	0.00477	0.00477	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—muscle cancer	0.00474	0.00474	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—muscle cancer	0.00474	0.00474	CcSEcCtD
Carbimazole—Pruritus—Etoposide—muscle cancer	0.0046	0.0046	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—muscle cancer	0.00443	0.00443	CcSEcCtD
Carbimazole—Angiopathy—Doxorubicin—muscle cancer	0.00431	0.00431	CcSEcCtD
Carbimazole—Malaise—Methotrexate—muscle cancer	0.0043	0.0043	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—muscle cancer	0.00427	0.00427	CcSEcCtD
Carbimazole—Alopecia—Doxorubicin—muscle cancer	0.00419	0.00419	CcSEcCtD
Carbimazole—Rash—Etoposide—muscle cancer	0.0041	0.0041	CcSEcCtD
Carbimazole—Dermatitis—Etoposide—muscle cancer	0.00409	0.00409	CcSEcCtD
Carbimazole—Headache—Etoposide—muscle cancer	0.00407	0.00407	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—muscle cancer	0.00406	0.00406	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—muscle cancer	0.00406	0.00406	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00403	0.00403	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—muscle cancer	0.00401	0.00401	CcSEcCtD
Carbimazole—Infection—Methotrexate—muscle cancer	0.00387	0.00387	CcSEcCtD
Carbimazole—Nausea—Etoposide—muscle cancer	0.00386	0.00386	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.00383	0.00383	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—muscle cancer	0.00382	0.00382	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—muscle cancer	0.00381	0.00381	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—muscle cancer	0.00378	0.00378	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—muscle cancer	0.00372	0.00372	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—muscle cancer	0.0037	0.0037	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00355	0.00355	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—muscle cancer	0.00352	0.00352	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—muscle cancer	0.00352	0.00352	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00349	0.00349	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—muscle cancer	0.00347	0.00347	CcSEcCtD
Carbimazole—Infection—Doxorubicin—muscle cancer	0.00335	0.00335	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.0033	0.0033	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—muscle cancer	0.00321	0.00321	CcSEcCtD
Carbimazole—Urticaria—Methotrexate—muscle cancer	0.00309	0.00309	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—muscle cancer	0.00308	0.00308	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00307	0.00307	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—muscle cancer	0.00287	0.00287	CcSEcCtD
Carbimazole—Feeling abnormal—Doxorubicin—muscle cancer	0.00278	0.00278	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—muscle cancer	0.00275	0.00275	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—muscle cancer	0.00266	0.00266	CcSEcCtD
Carbimazole—Hypersensitivity—Doxorubicin—muscle cancer	0.00248	0.00248	CcSEcCtD
Carbimazole—Rash—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Carbimazole—Headache—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Carbimazole—Pruritus—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Carbimazole—Nausea—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Carbimazole—Rash—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Carbimazole—Headache—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Carbimazole—Nausea—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
